Discovery of chalcone-quinazolinone hybrids as BRAF kinase inhibitors with potential anticancer activity: Design, synthesis, biological evaluation, and molecular modeling studies
Bioorganic Chemistry · 2026-11 · 184 · 110709
DOI: 10.1016/j.bioorg.2026.110709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Randa Atef Ibrahim Abdelaziz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, P.O. Box, 11562, Egypt; Egyptian…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Antineoplastic Agents, Protein Kinase Inhibitors, Drug Design. Die Arbeit nennt 49 Literaturangaben. Gefördert von: STDF.
Abstract (Originalsprache)
BRAF has emerged as an important target for inhibiting tumor cell proliferation. Accordingly, some chalcone-quinazolinone conjugates 4a-l were designed, synthesized and screened for their BRAF inhibitory activity. Compounds 4d, 4f, and 4l that revealed the most potent BRAFWT inhibition (IC50 = 0.572, 0.482, and 0.317 μM, respectively), in comparison to sorafenib (IC50 = 0.132 μM), were further tested for their efficacy on mutant BRAFV600E, where they showed promising inhibition (IC50 = 0.105, 0.067, and 0.275 μM, respectively), relative to vemurafenib (IC50 = 0.063 μM). The cytotoxic potential of 4d, 4f, and 4l demonstrated the selectivity of 4d and 4f towards HT-29 cancer cell line expressing BRAFV600E. Therefore, 4l was further evaluated for its inhibitory activity on EGFR, where it demonstrated potent inhibition with IC50 = 0.098 μM compared to gefitinib (IC50 = 0.037 μM). Moreover, 4f caused a cell cycle arrest at S and G2/M phases in HT-29 cells besides apoptotic induction. Potential biomarkers of apoptosis revealed the effectiveness of 4f in increasing Bax/Bcl-2 ratio by 19-fold, and upregulation of expression of Caspase-3 and Caspase-9 by 6- and 8-fold, respectively, relative to control HT-29 cancer cells. Molecular docking studies and molecular dynamics simulations were performed to correlate the biological activity of the newly synthesized compounds with their binding modes and investigate the dynamic stability of the 4f/BRAF complex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, P.O. Box, 11562, Egypt; Egyptian Intellectual Property Authority (EGIPA), Cairo, Egypt.
- Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt. Electronic address: iman.youssef.ghannam@gmail.com.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, P.O. Box, 11562, Egypt. Electronic address: Heba.abdelkhalek@pharma.cu.edu.eg.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, P.O. Box, 11562, Egypt; Lincoln Medical School, College of Health and Science, University of Lincoln, Lincoln, U…
- Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
- Cancer Biology and Genetics Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo 12622, Egypt; Biochemistry Department, Biotechnology Research Institute, National Research Centr…
Förderung
- STDF
Zitieren
APA
Abdelaziz, R. A. I., Ghannam, I. A. Y., Allam, H. A., El Kerdawy, A. M., Allam, R. M., Abo-Elfadl, M. T., & Abbas, S. E. (2026). Discovery of chalcone-quinazolinone hybrids as BRAF kinase inhibitors with potential anticancer activity: Design, synthesis, biological evaluation, and molecular modeling studies. Bioorganic Chemistry, 184, 110709. https://doi.org/10.1016/j.bioorg.2026.110709
Vancouver
Abdelaziz RAI, Ghannam IAY, Allam HA, El Kerdawy AM, Allam RM, Abo-Elfadl MT, et al. Discovery of chalcone-quinazolinone hybrids as BRAF kinase inhibitors with potential anticancer activity: Design, synthesis, biological evaluation, and molecular modeling studies. Bioorganic Chemistry. 2026;184:110709. doi:10.1016/j.bioorg.2026.110709
BibTeX
@article{Abdelaziz2026,
author = {Abdelaziz, Randa Atef Ibrahim and Ghannam, Iman Ahmed Youssef and Allam, Heba Abdelrasheed and El Kerdawy, Ahmed Mahmoud and Allam, Rasha Mousa and Abo-Elfadl, Mahmoud Taha and Abbas, Safinaz El-Sayed},
title = {Discovery of chalcone-quinazolinone hybrids as BRAF kinase inhibitors with potential anticancer activity: Design, synthesis, biological evaluation, and molecular modeling studies},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {184},
pages = {110709},
doi = {10.1016/j.bioorg.2026.110709}
}
EUVIMED